Using population‐based cancer registry data, the present study documents the changes in prostate cancer incidence trends coinciding with the release of the PLCO and ERSPC studies and recent USPSTF PSA screening recommendations by month of diagnosis. Here, KLK3 is linked to prostate carcinoma.